FREYR B2B Case Studies & Customer Successes

FREYR logo

Freyr is a Global Regulatory Solutions and Services company, focusing on the entire Regulatory value-chain ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions to post approval maintenance, Labeling, Artwork Change Management for Pharm...

Case Studies

Showing 67 FREYR Customer Success Stories

search button

American Multinational Pharmaceutical Company achieves swift MAH transfer and artwork updates with FREYR

American Multinational Pharmaceutical Company accelerates MAH transfer and artwork updates with Freyr

a China-based biopharmaceutical company achieves smooth IND approval in China with FREYR regulatory support

China-based Biopharmaceutical Company logo

a China-based biopharmaceutical company achieves IND approval for its COVID-19 vaccine with FREYR regulatory support

China-based Biopharmaceutical Company logo

a China-based pharmaceutical company achieves successful US FDA DMF submission with Freyr

a China-based pharmaceutical company achieves successful FDA DMF submission with FREYR

a danish specialty pharmaceutical company achieves quality and compliance across 35 countries with FREYR end-to-end artwork support

a Danish specialty pharmaceutical company achieves compliant artwork operations across 35 countries with Freyr

a Dubai-based healthcare company achieves successful SFDA registration of Paclitaxel Phares with Freyr Solutions

a Dubai-based Healthcare Company achieves timely SFDA registration of Paclitaxel with FREYR

a Dutch biotechnology company strengthens FDA regulatory readiness with FREYR’s USDMF submission support

a Dutch-based biotechnology company achieves successful USDMF submission with FREYR

a European multinational pharmaceutical company achieves 100% right-first-time labeling submissions with Freyr

a France-based biopharmaceutical company achieves high-impact manuscript publication with FREYR

German Multinational Pharmaceutical and Life Sciences Company achieves successful OTC market switch in Brazil with FREYR

a German multinational pharmaceutical and life sciences company improves SaMD documentation consistency with FREYR

German Multinational Pharmaceutical and Life Sciences Company achieves successful OTC market switch in Brazil with FREYR

a German pharmaceutical company renews Mexico marketing authorization with Freyr LATAM

a German pharmaceutical company achieves zero-objection 5-year MA renewal in Mexico with Freyr LATAM

a global consumer health organisation achieves 81% priority agency coverage with Freyr's global regulatory intelligence solution

a global medical device manufacturer achieves rapid regulatory resource ramp-up with FREYR staff augmentation

a global pharmaceutical company achieves first-cycle US FDA approval with Freyr regulatory support

Global Pharmaceutical Company logo

a Hungary-based pharmaceutical company achieves smoother regulatory transfer and K-DMF holding in South Korea with FREYR

an Indian multinational pharmaceutical giant achieves integrated post-acquisition regulatory operations with Freyr

an Indian multinational pharmaceutical giant achieves audit-ready integrated management processes with FREYR

a major Indian multinational pharmaceutical company achieves audit-ready compliance and process standardization with Freyr's Integrated Management System

an Innovative Medicines Company achieves regulatory compliance and market expansion with FREYR

an Italian multinational pharmaceutical company achieves timely FDA CARES Act compliance with Freyr

an Italian multinational pharmaceutical company achieves EU and USA market entry with FREYR regulatory strategy

Italian Multinational Pharmaceutical Company achieves successful FDA CARES Act 2023 submission with FREYR

a Japanese drug manufacturer achieves streamlined US market entry with FREYR

a Japanese midsize global pharma and biotech company achieves 100% on-time submissions and 50% cost savings with Freyr

a Japanese midsize global pharmaceutical and biotechnology company achieves 100% on-time submissions and over 50% cost savings with FREYR

a Japanese pharmaceutical and biotechnology company accelerates global regulatory submissions with FREYR

a Japanese pharmaceutical and biotechnology company accelerates global regulatory submissions with FREYR

a Korea-based Biotechnology Manufacturer Achieves Successful BLA Submission and LATAM/APAC Product Registration with FREYR

a large pharmaceutical company achieves clearer FDA guidance for a complex generic injectable with Freyr

a leading biopharmaceutical company achieves submission-ready labeling compliance with FREYR

a leading Canada-based generic manufacturer achieves Health Canada labeling compliance with Freyr regulatory labeling support

a leading Canada-based pharmaceutical company achieves zero artwork recalls and significant cost savings with FREYR

a leading Canada-based pharmaceutical company achieves zero artwork recalls and cost savings with Freyr

a leading diagnostics manufacturer achieves IVDR compliance and 30% cost reduction with FREYR

a leading US-based pharmaceutical manufacturer achieves seamless labeling transition for 1,500+ artworks with Freyr

a pharma giant clarifies FDA requirements for a complex generic injectable product with FREYR

a pharmaceutical company achieves first-cycle USFDA approval for a biosimilar with Freyr

a South Korea-based pharmaceutical company streamlines LATAM MAA submission for ENVLO with FREYR

a South Korea/China-based biopharma company achieves IND approval in China with FREYR’s sample test and regulatory support

a Swiss biologics company accelerates China BLA sample testing with FREYR

Swiss Biopharmaceutical Company accelerates Brazil BLA approval with FREYR regulatory support

a Switzerland-based biopharmaceutical company achieves timely BLA sample testing in China with Freyr regulatory operations support

a U.S.-based pharmaceutical company achieves error-free South Korea regulatory publishing with Freyr

a UK-based pharmaceutical company achieves compliant, efficient MLR review with Freyr

a US-based multinational pharmaceutical company achieves EAEU eCTD compliance with Freyr

a UK-based pharmaceutical company achieves successful USFDA-compliant ad-promo review with Freyr

a UK-based pharmaceutical company achieves 100% GMP compliance with FREYR's 2-week audit support

a US-based pharmaceutical company achieves seamless regulatory continuity with FREYR

a US generic pharma company achieves regulatory compliance and efficient labeling support with FREYR

a US pharma company achieves zero regulatory rejections with Freyr

a US-based leading pharmaceutical manufacturer achieves seamless labeling transition for 1,500+ artworks with FREYR

a US-based multinational company achieves eCTD compliance in EAEU with FREYR

a US-based pharmaceutical company achieves seamless management of 70+ ANDAs and NDAs with FREYR

a US-based pharmaceutical manufacturer achieves 100% quality and on-time artwork updates for 1,500+ injectables with FREYR

a USA Pharmaceutical Company achieves compliant, error-free regulatory publishing in South Korea with FREYR

a USA-based biopharmaceutical company maintains IND status with Freyr

a US-based life sciences logistics firm achieves full GDP compliance with FREYR

a USA-based life sciences logistics firm achieves full GDP compliance with Freyr

a USA-based pharmaceutical consultant successfully submits YY201 IND with Freyr regulatory support

No matching case studies

Asigra

163 Case Studies

Barco

246 Case Studies

BZ Marketing

14 Case Studies